Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-06-06 Sale | 2022-06-07 7:39 pm | Zosano Pharma Corp | ZSAN | Matthews Christine Chief Financial Officer | 82 | $0.71 | $58 | 4,183 (Direct) | View |
| 2022-06-06 Sale | 2022-06-07 7:37 pm | Zosano Pharma Corp | ZSAN | Lo Steven Chief Executive Officer | 442 | $0.71 | $314 | 13,163 (Direct) | View |
| 2022-03-31 Sale | 2022-04-01 9:09 pm | Zosano Pharma Corp | ZSAN | Matthews Christine Chief Financial Officer | 8,116 | $0.2101 | $1,705 | 146,425 (Direct) | View |
| 2022-03-31 Sale | 2022-04-01 9:08 pm | Zosano Pharma Corp | ZSAN | KELLERMAN DONALD J VP, Clinical Dev & Med Affairs | 4,006 | $0.2101 | $842 | 56,331 (Direct) | View |
| 2022-03-31 Sale | 2022-04-01 9:07 pm | Zosano Pharma Corp | ZSAN | Lo Steven Chief Executive Officer | 23,633 | $0.2101 | $4,965 | 460,709 (Direct) | View |
| 2021-11-23 Sale | 2021-11-24 5:53 pm | Zosano Pharma Corp | ZSAN | GREATHOUSE KENNETH Director | 10,000 | $0.6018 | $6,018 | 43,500 (Direct) | View |
| 2021-06-04 Sale | 2021-06-07 6:44 pm | Zosano Pharma Corp | ZSAN | Lo Steven Chief Executive Officer | 13,158 | $0.805 | $10,592 | 365,592 (Direct) | View |
| 2021-06-04 Sale | 2021-06-07 6:43 pm | Zosano Pharma Corp | ZSAN | Lewis Hayley See Remarks | 1,709 | $0.805 | $1,376 | 49,779 (Direct) | View |
| 2021-06-04 Sale | 2021-06-07 6:42 pm | Zosano Pharma Corp | ZSAN | KELLERMAN DONALD J VP, Clinical Dev & Med Affairs | 1,709 | $0.805 | $1,376 | 50,337 (Direct) | View |
| 2021-06-04 Sale | 2021-06-07 6:41 pm | Zosano Pharma Corp | ZSAN | Matthews Christine Chief Financial Officer | 1,709 | $0.805 | $1,376 | 98,291 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-12-07 Option Award | 2021-12-09 6:35 pm | N/A 2031-12-06 | Zosano Pharma Corp | ZSAN | Yang Elaine Director | 90,000 | $0 | 90,000 (Direct) | View |
| 2021-10-15 Option Award | 2021-10-19 9:36 pm | N/A 2031-10-14 | Zosano Pharma Corp | ZSAN | KELLERMAN DONALD J VP, Clinical Dev & Med Affairs | 30,000 | $0 | 80,337 (Direct) | View |
| 2021-10-15 Option Award | 2021-10-19 9:35 pm | N/A 2031-10-14 | Zosano Pharma Corp | ZSAN | Matthews Christine Chief Financial Officer | 168,750 | $0 | 267,041 (Direct) | View |
| 2021-10-15 Option Award | 2021-10-19 9:34 pm | N/A 2031-10-14 | Zosano Pharma Corp | ZSAN | Lo Steven Chief Executive Officer | 356,250 | $0 | 721,842 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 9:36 pm | N/A 2031-06-09 | Zosano Pharma Corp | ZSAN | Grais Linda Director | 45,000 | $0 | 52,500 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 8:38 pm | N/A 2031-06-09 | Zosano Pharma Corp | ZSAN | ELMS STEVE Director | 45,000 | $0 | 2,770,726 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 8:36 pm | N/A 2031-06-09 | Zosano Pharma Corp | ZSAN | GREATHOUSE KENNETH Director | 45,000 | $0 | 83,500 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 8:35 pm | N/A 2021-06-09 | Zosano Pharma Corp | ZSAN | XANTHOPOULOS KLEANTHIS G Director | 45,000 | $0 | 53,596 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 8:31 pm | N/A 2031-06-09 | Zosano Pharma Corp | ZSAN | Hagan Joseph P Director | 45,000 | $0 | 52,500 (Direct) | View |
| 2021-05-24 Option Award | 2021-05-25 6:29 pm | N/A 2031-05-23 | Zosano Pharma Corp | ZSAN | McGee Kathy M. Director | 90,000 | $0 | 90,000 (Direct) | View |
| 2021-05-17 Option Award | 2021-05-18 7:45 pm | N/A N/A | Zosano Pharma Corp | ZSAN | GREATHOUSE KENNETH Director | 21,000 | $0.7291 | 38,500 (Direct) | View |
| 2021-03-30 Option Award | 2021-04-01 9:33 pm | N/A 2031-03-29 | Zosano Pharma Corp | ZSAN | Lo Steven Chief Executive Officer | 697,500 | $0 | 843,750 (Direct) | View |
| 2021-03-30 Option Award | 2021-04-01 9:33 pm | N/A 2031-03-29 | Zosano Pharma Corp | ZSAN | Lewis Hayley See Remarks | 97,500 | $0 | 116,488 (Direct) | View |
| 2021-03-30 Option Award | 2021-04-01 9:31 pm | N/A 2031-03-29 | Zosano Pharma Corp | ZSAN | KELLERMAN DONALD J VP, Clinical Dev & Med Affairs | 97,500 | $0 | 117,046 (Direct) | View |
| 2021-03-30 Option Award | 2021-04-01 9:30 pm | N/A 2031-03-29 | Zosano Pharma Corp | ZSAN | Matthews Christine Chief Financial Officer | 243,750 | $0 | 262,500 (Direct) | View |
| 2021-03-18 Option Award | 2021-03-19 6:13 pm | N/A 2031-03-17 | Zosano Pharma Corp | ZSAN | Lo Steven Chief Executive Officer | 450,000 | $0 | 450,000 (Direct) | View |
| 2020-06-25 Option Award | 2020-06-29 9:57 pm | N/A N/A | Zosano Pharma Corp | ZSAN | GREATHOUSE KENNETH Director | 7,500 | $0 | 17,500 (Direct) | View |
| 2020-06-25 Option Award | 2020-06-29 9:56 pm | N/A N/A | Zosano Pharma Corp | ZSAN | Grais Linda S Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2020-06-25 Option Award | 2020-06-29 9:55 pm | N/A N/A | Zosano Pharma Corp | ZSAN | Lo Steven Chief Executive Officer | 146,250 | $0 | 146,250 (Direct) | View |
| 2020-06-25 Option Award | 2020-06-29 9:55 pm | N/A N/A | Zosano Pharma Corp | ZSAN | XANTHOPOULOS KLEANTHIS G Director | 7,500 | $0 | 8,596 (Direct) | View |
| 2020-06-25 Option Award | 2020-06-29 9:54 pm | N/A N/A | Zosano Pharma Corp | ZSAN | Hagan Joseph P Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2020-06-25 Option Award | 2020-06-29 9:52 pm | N/A N/A | Zosano Pharma Corp | ZSAN | WALKER JOHN PETER Director | 7,500 | $0 | 116,511 (Direct) | View |
| 2020-06-25 Option Award | 2020-06-29 9:52 pm | N/A N/A | Zosano Pharma Corp | ZSAN | Lewis Hayley See Remarks | 18,750 | $0 | 18,988 (Direct) | View |
| 2020-06-25 Option Award | 2020-06-29 9:50 pm | N/A N/A | Zosano Pharma Corp | ZSAN | KELLERMAN DONALD J VP, Clinical Dev & Med Affairs | 18,750 | $0 | 19,546 (Direct) | View |
| 2020-06-25 Option Award | 2020-06-29 9:48 pm | N/A N/A | Zosano Pharma Corp | ZSAN | Matthews Christine Chief Financial Officer | 18,750 | $0 | 18,750 (Direct) | View |
| 2020-06-25 Option Award | 2020-06-29 9:47 pm | N/A N/A | Zosano Pharma Corp | ZSAN | ELMS STEVE Director | 7,500 | $0 | 2,725,766 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 6:43 pm | N/A 2030-06-02 | Zosano Pharma Corp | ZSAN | WALKER JOHN PETER Director | 15,000 | $0 | 124,011 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 5:11 pm | N/A 2030-06-02 | Zosano Pharma Corp | ZSAN | Lo Steven Chief Executive Officer | 292,500 | $0 | 292,500 (Direct) | View |